Gastric cancer remains a major global health challenge, responsible for significant mortality worldwide. The human gut ...
Gastrointestinal dysmotility commonly follows thermal injuries, such as burns. This study aimed to investigate the effects and mechanisms of electroacupuncture (EA) on burn-induced gastric dysmotility ...
Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...
Phase II preoperative pembrolizumab for MSI high or MSS/PD-L1 gastric cancer followed by surgery and adjuvant therapy with pembrolizumab (NCT03257163): Results of a multicenter study. This is an ASCO ...
Following surgical treatment of gastric cancer -- often a complete or partial gastrectomy -- long-term cancer care is ...
Givastomig is designed to simultaneously target CLDN18.2 and 4-1BB. CLDN18.2 is a tight junction protein that is typically ...
Last week, the FDA responded positively to Phathom Pharmaceuticals (PHAT) Citizen Petition, confirming VOQUEZNA’s regulatory exclusivity through May 2032. This was a major de-risking event, ...
This case report details an ST-segment elevation due to ileus and gastric dilation. The ECG recorded in a man in his 70s with nausea, vomiting and epigastric discomfort showed ST-segment elevation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results